Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed BSE that its Board of Directors will meet on Wednesday, February 11, 2026, in New Delhi to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2025. The notice has been issued under Regulation 29 of the SEBI LODR Regulations. The company has also mentioned that the trading window for designated persons and their immediate relatives will remain closed until February 13, 2026, in line with insider trading regulations. No financial figures or business details have been disclosed in this filing.
This is a routine pre-results intimation with no direct impact on stock price. Investors should watch the actual Q3FY26 results announcement on or after February 11, 2026, for any meaningful performance update from the company.